FBRX
Price
$0.73
Change
-$0.05 (-6.41%)
Updated
Apr 19, 6:59 PM EST
24 days until earnings call
NVIVQ
Price
$0.32
Change
-$0.00 (-0.00%)
Updated
Feb 12, 6:59 PM EST
17 days until earnings call
Ad is loading...

Analysis and predictions FBRX vs NVIVQ

Header iconFBRX vs NVIVQ Comparison
Open Charts FBRX vs NVIVQBanner chart's image
Forte Biosciences
Price$0.73
Change-$0.05 (-6.41%)
Volume$6.12K
CapitalizationN/A
INVIVO THERAPEUTICS
Price$0.32
Change-$0.00 (-0.00%)
Volume$775.8K
CapitalizationN/A
View a ticker or compare two or three
FBRX vs NVIVQ Comparison Chart

Loading...

FBRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
FBRX vs. NVIVQ commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBRX is a Hold and NVIVQ is a Hold.

COMPARISON
Comparison
Apr 20, 2024
Stock price -- (FBRX: $0.78 vs. NVIVQ: $0.37)
Brand notoriety: FBRX and NVIVQ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBRX: 175% vs. NVIVQ: 21%
Market capitalization -- FBRX: $28.39M vs. NVIVQ: $1.15M
FBRX [@Biotechnology] is valued at $28.39M. NVIVQ’s [@Biotechnology] market capitalization is $1.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $553.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBRX’s FA Score shows that 0 FA rating(s) are green whileNVIVQ’s FA Score has 1 green FA rating(s).

  • FBRX’s FA Score: 0 green, 5 red.
  • NVIVQ’s FA Score: 1 green, 4 red.
According to our system of comparison, both FBRX and NVIVQ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBRX’s TA Score shows that 6 TA indicator(s) are bullish.

  • FBRX’s TA Score: 6 bullish, 3 bearish.

Price Growth

FBRX (@Biotechnology) experienced а +8.33% price change this week, while NVIVQ (@Biotechnology) price change was -0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.81%. For the same industry, the average monthly price growth was -5.21%, and the average quarterly price growth was +1226.26%.

Reported Earning Dates

FBRX is expected to report earnings on Aug 12, 2024.

NVIVQ is expected to report earnings on May 06, 2024.

Industries' Descriptions

@Biotechnology (-6.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FBRX with price predictions.
OPEN
A.I.dvisor published
a Summary for NVIVQ with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FBRX($28.4M) has a higher market cap than NVIVQ($1.15M). FBRX YTD gains are higher at: -5.075 vs. NVIVQ (-49.452).
FBRXNVIVQFBRX / NVIVQ
Capitalization28.4M1.15M2,478%
EBITDAN/AN/A-
Gain YTD-5.075-49.45210%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
FBRX vs NVIVQ: Fundamental Ratings
FBRX
NVIVQ
OUTLOOK RATING
1..100
208
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4464
P/E GROWTH RATING
1..100
5297
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVIVQ's Valuation (23) in the Biotechnology industry is significantly better than the same rating for FBRX (98) in the null industry. This means that NVIVQ’s stock grew significantly faster than FBRX’s over the last 12 months.

NVIVQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FBRX (100) in the null industry. This means that NVIVQ’s stock grew similarly to FBRX’s over the last 12 months.

NVIVQ's SMR Rating (98) in the Biotechnology industry is in the same range as FBRX (98) in the null industry. This means that NVIVQ’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's Price Growth Rating (44) in the null industry is in the same range as NVIVQ (64) in the Biotechnology industry. This means that FBRX’s stock grew similarly to NVIVQ’s over the last 12 months.

FBRX's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for NVIVQ (97) in the Biotechnology industry. This means that FBRX’s stock grew somewhat faster than NVIVQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBRX
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 24 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
FBRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SERA9.790.11
+1.14%
Sera Prognostics
COLM75.540.54
+0.72%
Columbia Sportswear Company
AIG72.990.41
+0.56%
American International Group
DCPH14.23-0.49
-3.33%
Deciphera Pharmaceuticals
ICLK3.37-0.54
-13.81%
iClick Interactive Asia Group Limited

FBRX and

Correlation & Price change

A.I.dvisor tells us that FBRX and NVIVQ have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBRX and NVIVQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
+5.41%
NVIVQ - FBRX
32%
Poorly correlated
-1.13%
EQ - FBRX
32%
Poorly correlated
-3.35%
FBIO - FBRX
32%
Poorly correlated
+2.26%
AXON - FBRX
31%
Poorly correlated
-0.74%
CRIS - FBRX
30%
Poorly correlated
-4.58%
More

NVIVQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVIVQ has been loosely correlated with ATXI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NVIVQ jumps, then ATXI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVIVQ
1D Price
Change %
NVIVQ100%
-1.13%
ATXI - NVIVQ
37%
Loosely correlated
-0.37%
EQ - NVIVQ
31%
Poorly correlated
-3.35%
BRTX - NVIVQ
30%
Poorly correlated
+3.60%
SAGE - NVIVQ
29%
Poorly correlated
+3.70%
RANI - NVIVQ
29%
Poorly correlated
-22.93%
More